بدائل البحث:
significantly altered » significantly affected (توسيع البحث), significantly elevated (توسيع البحث), significantly lower (توسيع البحث)
altered decrease » altered release (توسيع البحث), observed decrease (توسيع البحث), teer decrease (توسيع البحث)
shape decrease » shape increases (توسيع البحث), step decrease (توسيع البحث), showed decreased (توسيع البحث)
small decrease » small increased (توسيع البحث)
significantly altered » significantly affected (توسيع البحث), significantly elevated (توسيع البحث), significantly lower (توسيع البحث)
altered decrease » altered release (توسيع البحث), observed decrease (توسيع البحث), teer decrease (توسيع البحث)
shape decrease » shape increases (توسيع البحث), step decrease (توسيع البحث), showed decreased (توسيع البحث)
small decrease » small increased (توسيع البحث)
-
141
-
142
-
143
Data Sheet 1_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and...
منشور في 2024"…Known associations between genomic alterations and immunotherapy markers were observed including significantly lower TMB levels in tumors with therapy-associated alterations and significantly higher PD-L1 levels in tumors with ALK, MET, BRAF, or ROS1 driver mutations. …"
-
144
-
145
-
146
Radial Ferrofluid Droplet Generation on a 2-D Star-Shaped Nozzle with 4 Vertices.
منشور في 2025الموضوعات: -
147
Radial Ferrofluid Droplet Generation on a 2-D Star-Shaped Nozzle with 3 Vertices.
منشور في 2025الموضوعات: -
148
-
149
-
150
Genetic alterations of CD70 in DLBCL.
منشور في 2024"…Compared with DLBCL patients with CD70 mutation, methylation levels of PKHD1, MAS1, and FIP1L1 were obviously increased, whereas RPL10A, MARCH10, FAM45A, and FAM45B were significantly decreased in DLBCL patients with CD70 mutation. …"
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
-
159
Presentation 1_Efficacy of disitamab vedotin in non-small cell lung cancer with HER2 alterations: a multicenter, retrospective real-world study.pdf
منشور في 2024"…Background<p>Non-small cell lung cancer (NSCLC) with human epidermal growth factor receptor 2 (HER2) alterations poses a substantial treatment challenge. …"
-
160